Evidence map›Paper›PMID 37721956›Full record

ArticlePLoS genetics2023

Neuronal mTORC1 inhibition promotes longevity without suppressing anabolic growth and reproduction in C. elegans.

Hannah J Smith, Anne Lanjuin, Arpit Sharma, Aditi Prabhakar, Ewelina Nowak, Peter G Stine, Rohan Sehgal, Klement Stojanovski, Benjamin D Towbin, William B Mair

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. ConsideringCells · 2024
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Hannah J SmithDept. Molecular Metabolism, Harvard TH Chan School of Public Health, Massachusetts, United States of America.ORCID 0000-0003-2524-8929
Anne LanjuinDept. Molecular Metabolism, Harvard TH Chan School of Public Health, Massachusetts, United States of America.
Arpit SharmaDept. Molecular Metabolism, Harvard TH Chan School of Public Health, Massachusetts, United States of America.
Aditi PrabhakarDept. Molecular Metabolism, Harvard TH Chan School of Public Health, Massachusetts, United States of America.
Ewelina NowakDept. Molecular Metabolism, Harvard TH Chan School of Public Health, Massachusetts, United States of America.
Peter G StineDept. Molecular Metabolism, Harvard TH Chan School of Public Health, Massachusetts, United States of America.
Rohan SehgalDept. Molecular Metabolism, Harvard TH Chan School of Public Health, Massachusetts, United States of America.
Klement StojanovskiInstitute for Cell Biology, University of Bern, Bern, Switzerland.
Benjamin D TowbinInstitute for Cell Biology, University of Bern, Bern, Switzerland.
William B MairDept. Molecular Metabolism, Harvard TH Chan School of Public Health, Massachusetts, United States of America.ORCID 0000-0002-0661-1342
Harvard University · USUniversity of Bern · CH

Funding

Training Program in Molecular and Integrative Physiological SciencesT32HL007118 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI LU, QUAN · 1985 to 2025
$14.3M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Mechanisms Specific to the Beneficial Effects of Dietary RestrictionR01AG044346 · NIA · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI William B Mair · 2013 to 2026
$3.8M
Reversing Loss of Metabolic Homeostasis to Ameliorate Alzheimer's Disease PathogenicityR01AG067106 · NIA · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI MAIR, WILLIAM B · 2020 to 2024
$2.0M
Cell Non-autonomous Regulation of Aging via Neuronal TORC1R01AG059595 · NIA · HARVARD SCHOOL OF PUBLIC HEALTH · PI MAIR, WILLIAM B · 2018 to 2022
$2.0M
Targeting RNA homeostasis to promote healthy agingR01AG051954 · NIA · HARVARD SCHOOL OF PUBLIC HEALTH · PI MAIR, WILLIAM B · 2017 to 2020
$1.7M
Mechanisms of Aging Regulation by Neuronal mTORC1 in C. elegansF31AG076296 · NIA · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI SMITH, HANNAH J · 2022 to 2024
$100k
NHLBI NIH HHS T32 HL007118NIA NIH HHS F31 AG076296NIA NIH HHS R01 AG044346NIA NIH HHS R01 AG051954NIA NIH HHS R01 AG059595NIA NIH HHS R01 AG067106NIH HHS P40 OD010440
6 · The paper itself

Abstract

mTORC1 (mechanistic target of rapamycin complex 1) is a metabolic sensor that promotes growth when nutrients are abundant. Ubiquitous inhibition of mTORC1 extends lifespan in multiple organisms but also disrupts several anabolic processes resulting in stunted growth, slowed development, reduced fertility, and disrupted metabolism. However, it is unclear if these pleiotropic effects of mTORC1 inhibition can be uncoupled from longevity. Here, we utilize the auxin-inducible degradation (AID) system to restrict mTORC1 inhibition to C. elegans neurons. We find that neuron-specific degradation of RAGA-1, an upstream activator of mTORC1, or LET-363, the ortholog of mammalian mTOR, is sufficient to extend lifespan in C. elegans. Unlike raga-1 loss of function genetic mutations or somatic AID of RAGA-1, neuronal AID of RAGA-1 robustly extends lifespan without impairing body size, developmental rate, brood size, or neuronal function. Moreover, while degradation of RAGA-1 in all somatic tissues alters the expression of thousands of genes, demonstrating the widespread effects of mTORC1 inhibition, degradation of RAGA-1 in neurons only results in around 200 differentially expressed genes with a specific enrichment in metabolism and stress response. Notably, our work demonstrates that targeting mTORC1 specifically in the nervous system in C. elegans uncouples longevity from growth and reproductive impairments, and that many canonical effects of low mTORC1 activity are not required to promote healthy aging. These data challenge previously held ideas about the mechanisms of mTORC1 lifespan extension and underscore the potential of promoting longevity by neuron-specific mTORC1 modulation.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsAnimalsLongevityMammalsMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesReproductionCaenorhabditis elegans ProteinsMechanistic Target of Rapamycin Complex 1Multiprotein Complexes

Identifiers

PMID37721956
PMCPMC10538657
OpenAlexW4386825710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.